can glp 1 cause numbness Peripheral Neuropathy: Symptoms, Causes, Diagnosis, and Treatment Research has associated GLP-1 medications

- Avexitide is a novel, first-in-class GLP-1 receptor antagonist with the potential to treat hyperinsulinemic hypoglycemia - FDA Breakthrough Therapy Designation granted for avexitide for post-bariatric hypoglycemia (PBH) and congenital hyperinsulinism - Acquisition builds on Amylyx endocrine and neuroscience expertise and aligns with pipeline focus of delivering important potential treatment options to communities with high unmet needs - Phase 3 program for avexitide in PBH expected to begin in Q1 2025, with data readout anticipated in 2026

Logo Search icon User Icon ng nhp / ng k Ti khon Store Icon H thng ca hng Warranty Icon Bo hnh Phone Icon H tr khch hng Cart Icon 0 Ti ng dng Map icon Chn khu vc ca bn Trang ch Sc Khe - Lm p Thc Phm Chc Nng H Tr Lm p Vin Ung Sng Da D-Na Ci Thin Sm Nm Chuyn Su 60 Vin (HSD 06/2023)

A recent review by Gatto et al., published in May 2025, reached a similar conclusionsuggesting that GLP-1 receptor agonists may have a positive impact on musculoskeletal health

Aloe vera may also have a positive impact on GLP-1 production